On September 25, 2017, the FDA and lupus patients came together for a historic patient-focused drug development meeting.
Upcoming Events See all events >
No upcoming events.
Latest News See all stories >
Tickets on sale for sneak peek night of shopping and entertainment to benefit nonprofits.
The Lupus Patient-Focused Drug Development (PFDD) Meeting, a day-long event to advance lupus therapy development and inform FDA will be held Sept. 25.
New population-based analyses measure incidence and prevalence of lupus among these fast-growing U.S. populations.
This new research program provides $5 million that will greatly expand the number of lupus-specific research studies that can be supported through the DoD.